Cerebral small vessel disease (CSVD) is one of the most prevalent pathologic processes affecting 5% of people over 50 years of age and contributing to 45% of dementia cases. Increasing evidence has demonstrated the pathological roles of chronic hypoperfusion, impaired cerebral vascular reactivity, and leakage of the blood-brain barrier in CSVD. However, the pathogenesis of CSVD remains elusive thus far, and no radical treatment has been developed. NG2 glia, also known as oligodendrocyte precursor cells, are the fourth type of glial cell in addition to astrocytes, microglia, and oligodendrocytes in the mammalian central nervous system. Many novel functions for NG2 glia in physiological and pathological states have recently been revealed. In this review, we discuss the role of NG2 glia in CSVD and the underlying mechanisms. © 2022. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.
Yixi He, Zhenghao Li, Xiaoyu Shi, Jing Ding, Xin Wang. Roles of NG2 Glia in Cerebral Small Vessel Disease. Neuroscience bulletin. 2023 Mar;39(3):519-530
PMID: 36401147
View Full Text